Lundbeck reports results from long-term follow-up of epilepsy patients treated with bexicaserin

CARsgen Therapeutics presents CT0596 study data at 2005 ASH Annual Meeting

AsymBio starts commercial production at Shanghai Fengxian Manufacturing Base

Innovent Biologics and Takeda sign global strategic partnership

TransThera publishes clinical results from US-based Phase 2 trial of tinengotinib in CCA

Hope Medicine wins FDA Fast Track Designation for HMI-115 in endometriosis

Bayer launches Phase IIa trial of BAY 3401016 for Alport Syndrome

Orano Med and Roche advance pretargeted radioimmunotherapy into clinical phase

New Leqembi data indicates substantial delays in Alzheimer's progression

Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio

AvenCell Therapeutics receives IND clearance and CTA approval for AVC-203 for the treatment of relapsed/refractory B-cell malignancies

Eli Lilly's Jaypirca receives FDA approval for treatment of adults with relapsed or refractory CLL/SLL previously treated with covalent BTK inhibitor

Avetra unveils site-centric CRO operating model

Spinogenix reports approval of 'tazbentetol' as non-proprietary name for SPG302

Xeris Biopharma receives USPTO Notice of Allowance for XP-8121 patent